Medicare Bundled Payment Policies Could Cut Amgen’s Parsabiv Sales By 50%

Amgen ‘looks forward’ to working with CMS and Congress to shape Medicare reimbursement policies in a way that better ensures access.

Innovation In Dialysis Drugs Hampered By Medicare Policies?

More from Medicare

More from Government Payers